GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

UniDoc Health UDOC.CN · CAD

N/A · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.05

+11.11%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2026

Revenue

C$937,872

FY2021FY2026

Net income

−C$3.2m

FY2021FY2026

Free cash flow

−C$2.4m

FY2021FY2026

Shareholders' equity

−C$1.0m

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
RevenueC$937,872—————
Gross profitC$429,147—————
Research and developmentC$8,996—C$17,652C$12,091C$353,016—
Operating income−C$3.0m−C$5.8m−C$2.2m−C$1.4m−C$3.0m−C$237,300
Net income−C$3.2m−C$6.1m−C$2.3m−C$1.4m−C$3.0m−C$237,300
Diluted earnings per share-0.04-0.08-0.08-0.06-0.14-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assetsC$1.6mC$2.9mC$517,084C$320,467C$1.2mC$288,400
Total liabilitiesC$2.6mC$2.2mC$2.4mC$1.2mC$721,604C$425,131
Debt——C$13,470C$27,775——
Shareholders' equity−C$1.0mC$664,525−C$1.9m−C$900,788C$456,276−C$136,731
Shares outstanding87m76m29m22m22m20m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations−C$2.3m−C$7.4m−C$559,920−C$755,589−C$2.4mC$17,300
Capital spending−C$71,339−C$257,756—−C$62,768−C$51,239—
Free cash flow−C$2.4m−C$7.7m−C$559,920−C$818,357−C$2.4mC$17,300

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$153,284C$240,812C$238,471C$324,546C$134,043———
Gross profitC$19,481C$115,229C$97,873C$145,453C$70,592———
Operating income−C$518,397−C$914,840−C$605,200−C$807,514−C$677,848−C$757,006−C$1.5m−C$1.6m
Net income−C$540,206−C$1.1m−C$611,409−C$875,771−C$642,460−C$987,628−C$1.5m−C$1.6m
Diluted earnings per share-0.01-0.01-0.01-0.01-0.01-0.01-0.02-0.03
Cash from operations——−C$1.0m——−C$1.0m−C$2.0m−C$1.0m
Total assetsC$1.4mC$1.6mC$2.3mC$1.8mC$2.4mC$2.9mC$3.2mC$508,169
DebtC$36,121—————C$14,176C$13,877
Shareholders' equity−C$1.6m−C$1.0m−C$27,838−C$857,082C$20,543C$664,525C$1.6m−C$1.5m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income30.4%66.1%—
Net income33.6%68.6%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings-1.3-0.7-2.2-1.6-0.7-13.4
Price to sales4.6—————

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 1 Apr 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.